Naso Matteo, Trincianti Chiara, Tosca Maria Angela, Ciprandi Giorgio
Allergy Center, IRCCS Istituto Giannina Gaslini, 16100 Genoa, Italy.
Allergy Clinic, Casa di Cura Villa Montallegro, 16100 Genoa, Italy.
Nutrients. 2025 Apr 27;17(9):1476. doi: 10.3390/nu17091476.
Quercetin, a natural flavonoid, present in various vegetables and fruits, has garnered increasing attraction for its potential antiallergic properties. Its broad-spectrum activity depends on its anti-inflammatory, immunomodulatory, and antioxidant effects, which target the critical pathways involved in type 2-driven allergic inflammation. Quercetin inhibits mast cell degranulation, reduces the production of histamine and pro-inflammatory cytokines, and restores homeostasis of the immune system by modulating the Th1/Th2 and Treg/Th17 balances. Additionally, its antioxidant properties help to dampen oxidative stress, a critical factor in the pathophysiology of allergic diseases. In vitro studies have consistently demonstrated quercetin's ability to suppress allergic reactions. In contrast, in vivo studies, particularly in murine models of allergic rhinitis, have confirmed its efficacy in relieving symptoms (such as nasal itching, sneezing, rhinorrhea, and congestion) and dampening type 2 mucosal inflammation. Preclinical evidence also supports its therapeutic potential in asthma, conjunctivitis, atopic dermatitis, and food allergies. However, human studies are still scarce, as only two clinical trials investigated quercetin as a monotherapy. Both studies reported promising results, including symptom reduction and improved quality of life, though larger, randomized trials are needed to validate these findings. Some other studies have investigated multicomponent products that also contain quercetin. This review aimed to report and discuss the most recent in vitro and in vivo evidence on quercetin's application in allergic models. It also provides a comprehensive overview of human studies, highlighting its potential as an agent in food supplements to manage patients with allergic diseases. Moreover, this review introduces a new quercetin phospholipids formulation that may represent a keystone in clinical use. The literature search was based on a PubMed consultation considering the most recent (last five years) publications using the keywords "quercetin and allergic disease" and "quercetin and immune system".
槲皮素是一种天然黄酮类化合物,存在于各种蔬菜和水果中,因其潜在的抗过敏特性而越来越受到关注。其广谱活性取决于其抗炎、免疫调节和抗氧化作用,这些作用针对2型驱动的过敏性炎症所涉及的关键途径。槲皮素抑制肥大细胞脱颗粒,减少组胺和促炎细胞因子的产生,并通过调节Th1/Th2和Treg/Th17平衡来恢复免疫系统的稳态。此外,其抗氧化特性有助于减轻氧化应激,氧化应激是过敏性疾病病理生理学中的一个关键因素。体外研究一致证明了槲皮素抑制过敏反应的能力。相比之下,体内研究,特别是在变应性鼻炎小鼠模型中的研究,证实了其在缓解症状(如鼻痒、打喷嚏、流涕和鼻塞)和减轻2型粘膜炎症方面的疗效。临床前证据也支持其在哮喘、结膜炎、特应性皮炎和食物过敏中的治疗潜力。然而,人体研究仍然很少,因为只有两项临床试验将槲皮素作为单一疗法进行了研究。两项研究均报告了有前景的结果,包括症状减轻和生活质量改善,不过需要更大规模的随机试验来验证这些发现。其他一些研究调查了也含有槲皮素的多成分产品。本综述旨在报告和讨论关于槲皮素在过敏模型中应用的最新体外和体内证据。它还全面概述了人体研究,强调了其作为食品补充剂中治疗过敏性疾病患者的药物的潜力。此外,本综述介绍了一种新的槲皮素磷脂制剂,它可能是临床应用中的关键。文献检索基于对PubMed的查询,考虑了使用关键词“槲皮素与过敏性疾病”和“槲皮素与免疫系统”的最新(过去五年)出版物。